RE: RNS - funding for prostate trial prep27 Mar 2025 07:51
This is great news. Prostate is such a huge market opportunity. Given their experience with developing ChemoSeed in brain tumours they should be able to bring this ChemoSeed to market quickly. It also shows that the company is delivering on what it said in its admission document when it joined AIM. I am really pleased and excited with this announcement.